Otulfi 130 mg/26mL
ustekinumab-aauz · SOLUTION · Fresenius Kabi USA, LLC
No Recall History
Plain English
Otulfi is a solution containing ustekinumab-aauz at 130 mg/26mL, taken intravenous. Manufactured by Fresenius Kabi USA, LLC.
Key Facts
- Brand Name
- Otulfi
- Generic Name
- ustekinumab-aauz
- NDC Code (Product)
65219-828- Manufacturer
- Fresenius Kabi USA, LLC
- Strength
- 130 mg/26mL
- Dosage Form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761379
- Drug Class
- Interleukin-12 Antagonist [EPC]; Interleukin-23 Antagonist [EPC]
- Marketing Start
- 02/22/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is Otulfi used for?
Otulfi contains ustekinumab-aauz. It is a solution taken intravenous. Consult your doctor for specific uses.
Is Otulfi a controlled substance?
Otulfi is not classified as a controlled substance by the DEA.
What is the generic name for Otulfi?
The generic name for Otulfi is ustekinumab-aauz. There are 2 other brand versions of ustekinumab-aauz.
What is the NDC code for Otulfi 130 mg/26mL?
The NDC (National Drug Code) for Otulfi 130 mg/26mL is 65219-828, listed by Fresenius Kabi USA, LLC.